KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Resmed (RMD) Leases (2019 - 2025)

Resmed (RMD) has disclosed Leases for 7 consecutive years, with $165.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases rose 9.87% year-over-year to $165.9 million, compared with a TTM value of $165.9 million through Dec 2025, up 9.87%, and an annual FY2025 reading of $167.5 million, up 10.84% over the prior year.
  • Leases was $165.9 million for Q4 2025 at Resmed, up from $162.0 million in the prior quarter.
  • Across five years, Leases topped out at $167.5 million in Q2 2025 and bottomed at $123.4 million in Q3 2023.
  • Average Leases over 5 years is $142.6 million, with a median of $143.6 million recorded in 2021.
  • The sharpest move saw Leases decreased 12.2% in 2022, then increased 27.27% in 2024.
  • Year by year, Leases stood at $146.0 million in 2021, then fell by 12.2% to $128.2 million in 2022, then grew by 19.69% to $153.5 million in 2023, then fell by 1.6% to $151.0 million in 2024, then rose by 9.87% to $165.9 million in 2025.
  • Business Quant data shows Leases for RMD at $165.9 million in Q4 2025, $162.0 million in Q3 2025, and $167.5 million in Q2 2025.